| dc.contributor.author | Mc Lysaght, Aoife | en |
| dc.date.accessioned | 2017-09-21T09:44:03Z | |
| dc.date.available | 2017-09-21T09:44:03Z | |
| dc.date.issued | 2017 | en |
| dc.date.submitted | 2017 | en |
| dc.identifier.citation | Rice A., McLysaght A., Dosage sensitivity is a major determinant of human copy number variant pathogenicity, Nature Communications, 8, 2017, 14366 | en |
| dc.identifier.other | Y | en |
| dc.description | PUBLISHED | en |
| dc.description.sponsorship | We thank all members of the McLysaght research group for valuable discussions. This
work is supported by funding from the European Research Council under the European
Union’s Seventh Framework Programme (FP7/2007–2013)/European Research Council
grant agreement 30983 | en |
| dc.format.extent | 14366 | en |
| dc.relation.ispartofseries | Nature Communications | en |
| dc.relation.ispartofseries | 8 | en |
| dc.rights | Y | en |
| dc.title | Dosage sensitivity is a major determinant of human copy number variant pathogenicity | en |
| dc.type | Journal Article | en |
| dc.type.supercollection | scholarly_publications | en |
| dc.type.supercollection | refereed_publications | en |
| dc.identifier.peoplefinderurl | http://people.tcd.ie/mclysaga | en |
| dc.identifier.rssinternalid | 173439 | en |
| dc.identifier.doi | http://dx.doi.org/10.1038/ncomms14366 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.identifier.orcid_id | 0000-0003-2552-6220 | en |
| dc.identifier.uri | http://hdl.handle.net/2262/81789 | |
